News Quantified

Stock Stats

News Stats


All News	{{AllNewsCount}}
News Wires	{{NewsWiresCount}}
Media Monitoring	{{MoreOverCount}}
SEC Edgar Filings	{{SecEdgarFilingsCount}}
Upgrades	{{UpgradesCount}}
Downgrades	{{DowngradesCount}}
Initiated	{{InitiatesCount}}
Reiterated	{{ReiteratesCount}}
Last Earnings	{{LastEarnings}}
Last Earnings EPS	{{LastEps}}
Next Earnings	{{NextEarnings}}

Order Stats

Sub-Penny
{{SubPennyStr}}
Odd Lot
{{OddLotStr}}
Avg. bid-ask spread

{{GetAvgBidAskSpreadForScale}}
Avg. bid / ask size
{{GetAvgBidSizeForScale}} {{GetAvgAskSizeForScale}}

Shares at ask / bid
{{SharesAtAsk_AMP_Str}} {{SharesAtBid_AMP_Str}}
Off exchange
{{OffExchange}}

News

HOOKIPA Pharma Announces Enrollment Completion of Phase 1b Clinical Trial Evaluating HB-500 for the Treatment of HIV [Yahoo! Finance]

HOOKIPA Pharma Announces Enrollment Completion of Phase 1b Clinical Trial Evaluating HB-500 for the Treatment of HIV

Hookipa Pharma Inc (NASDAQ: HOOK) had its "neutral" rating re-affirmed by analysts at HC Wainwright.

Poolbeg Pharma plc (“Poolbeg”) and HOOKIPA Pharma Inc. (“HOOKIPA”) Update on Potential Combination of Poolbeg and HOOKIPA [Yahoo! Finance]

HOOKIPA Pharma Announces Notice to Shareholders Regarding U.K. Disclosure Requirements

8/8/2024

04:30 pm

hook

-7.1%

MISS

5/9/2024

07:01 am

hook

-3.7%

BEAT

3/22/2024

07:01 am

hook

-2.0%

MISS

Form SCHEDULE 13D/A HOOKIPA Pharma Inc. Filed by: SOFINNOVA CAPITAL VI FCPR

Form SCHEDULE 13G/A HOOKIPA Pharma Inc. Filed by: EcoR1 Capital, LLC

Form 8-K HOOKIPA Pharma Inc. For: Jan 29

Form DEFA14A HOOKIPA Pharma Inc.

Form 8-K HOOKIPA Pharma Inc. For: Jan 10

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}